Siemens and Bentley Systems Collaborate on Process Industries Academy Initiative
(from ACHEMA, World Forum for the Process Industries) − Siemens’ Process Industries and Drives and Digital Factories divisions are teaming up with Bentley Systems’ Bentley Institute to establish a Process Industries Academy that will support the companies’ joint vision for cloud services and digital workflows in engineering and operations. The Process Industries Academy will help organizations to better understand and develop an effective digital strategy across all aspects of the asset lifecycle, based on the practical experience and knowledge of the industry’s leading experts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612006205/en/
The Process Industries Academy helps organizations develop digital strategy best practices based on practical knowledge from industry experts. (Photo: Bentley Systems)
With recent fluctuations in the oil, gas, and global energy markets, and the subsequent impact on related process manufacturing sectors, established ways of working in the process industries are now being challenged across the entire project lifecycle. Fewer capital investments in greenfield projects, and an increased focus on optimizing productivity, performance and utilization of existing assets, have prompted the process industries to examine new ways to increase competitiveness and operating revenues.
An optimal approach to project delivery and asset performance addresses the interactions and balance between an organization’s capabilities, its people, the underlying business processes and methods, all coupled with the latest technology, to consistently improve its business outcomes.
Based on the experience and knowledge of the industry’s leading experts, the Process Industries Academy will provide sessions focusing on real-world examples of the key aspects of a digital approach to capital project delivery and asset operations. Participants will discover how developing a clear digital strategy for improved collaboration, communication, and coordination between project teams creates an ideal environment to optimize information creation and digital workflows.
Eckard Eberle, CEO, Process Automation, Process Industries and Drives Division, Siemens AG, said, “The Process Industries Academy supports the development of industry best-practice approaches, while respecting the culture and traditions within today’s process industries. Our shared vision for the academy is to offer a practical, effective means for asset owners, decision makers, and program and project managers to understand the interactions and balance between teams, processes, and technologies so they can see improved project delivery and asset performance.”
Alan Lamont, vice president of Digital Advancement Academies for Bentley Systems, said, “The Process Industries Academy will offer industry professionals an environment to learn and share practical insights about business process improvements enabled by technology, so they can educate and equip their teams to be more productive and achieve the best outcomes. With academy sessions, we hope to help participants to develop a better understanding of their role and the benefits across the asset lifecycle, with practical, real-world examples of “Going Digital” to advance capital project delivery and asset operations.”
Process Industries Academies will be situated in the following locations to support the global process industry:
- Karlsruhe, Germany at Siemens’ Process Automation World
- Houston, Texas, U.S. in Bentley’s Digital Advancement Academy
- Shanghai, China at Siemens’ Process Industry Center of Excellence
The first academy session is scheduled for November 14, 2018 in Karlsruhe at Siemens Process Automation World. A half-day preview of the Process Industries Academy will be featured during Bentley’s Year in Infrastructure 2018 Conference in London on Monday, October 15.
Caption and image link:
The
Process Industries Academy will help organizations develop a digital
strategy based on practical experience and knowledge from leading
experts.
Attribution: Photo courtesy of Bentley Systems
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide. www.siemens.com
Bentley Institute advances the infrastructure professions by encouraging and supporting going digital. Its initiatives advance and attract current and future infrastructure professionals through continuous learning about technology solutions, as well as project delivery and asset performance best practices. Bentley Institute’s Digital Advancement Academies facilitate an environment and a culture of innovation via awareness sessions, forums, and targeted seminars and working groups, helping to ensure that all project collaborators fully understand the digital processes, standards, and deliverables expected for successful project outcomes. www.bentley.com/learn
Bentley Systems, Incorporated is a global leader dedicated to providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing infrastructure. Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, and is on track to surpass an annual revenue run rate of $700 million. Since 2012, Bentley has invested more than $1 billion in research, development, and acquisitions. www.bentley.com
Bentley and the Bentley logo are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180612006205/en/
Contact information
Bentley Systems, Incorporated
Press Contact:
Jennifer Maguire
+1
610-458-2695
jennifer.maguire@bentley.com
Follow
us on Twitter:
@BentleySystems
or
Siemens
AG
Evelyne Kadel
evelyne.kadel@siemens.com
+49
211 69161003
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 20:59:00 EEST | Press release
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who
Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 16:05:00 EEST | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 15:30:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include
Schlumberger Announces Second-Quarter 2019 Results19.7.2019 14:00:00 EEST | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente
Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 13:46:00 EEST | Press release
Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 13:00:00 EEST | Press release
Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom